|
M2 Presswire
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 5135 articles |
 Page 5 of 69 
|
FDA proposes regulation for registering food facilities.
January 30, 2003
Prior notice of imported food shipments proposal.
January 30, 2003
Manning Publications announces the release of: Programming Mac OS X A ...
January 30, 2003
Northwest Airlines CEO to present at Goldman Sachs Transportation Conf...
January 30, 2003
Temporary closure of the US Consulate Nuevo Laredo; Press statement --...
January 30, 2003
Expansion of Tengiz Oil Project in Kazakhstan; Press statement -- Rich...
January 30, 2003
Constitutional reform process in the Kyrgyz Republic; Press statement ...
January 30, 2003
Contracts.
January 30, 2003
Republic of Congo responds to questions raised in Women's Anti-Discrim...
January 30, 2003
IBM announces Business Partner initiative for small and medium busines...
January 30, 2003
SignalGene Inc.
January 30, 2003
Serologicals.
January 30, 2003
Sheffield Pharmaceuticals.
January 30, 2003
Sepragen.
January 30, 2003
Senomyx.
January 30, 2003
Scios.
January 30, 2003
Select Therapeutics.
January 30, 2003
Sangamo BioSciences.
January 30, 2003
Rigel Pharmaceuticals, Inc.
January 30, 2003
ReNeuron.
January 30, 2003
Repligen.
January 30, 2003
Quintiles.
January 30, 2003
Tachykinins Receptor Antagonists: One Therapeutic Class for Multiple I...
January 30, 2003
Ghrelin: The future of obesity therapeutics.
January 30, 2003
Glycogen synthase kinase 3 inhibitors: Proof of concept and therapeuti...
January 30, 2003
Histone Deacetylase Inhibitors: Redefining Pharmaceutical Approaches t...
January 30, 2003
Therapeutic and Pharmaceutical Approaches to COPD.
January 30, 2003
Male and female sexual dysfunction: Blockbuster indication for multipl...
January 30, 2003
Angiotensin as a target for the treatment of Alzheimer's disease, anxi...
January 30, 2003
Vical.
January 30, 2003
Vertex.
January 30, 2003
Versicor Inc.
January 30, 2003
Vasogen.
January 30, 2003
Valentis.
January 30, 2003
Urologix.
January 30, 2003
TranXenoGen.
January 30, 2003
Unigene Laboratories.
January 30, 2003
Tularik.
January 30, 2003
Trinity Bio.
January 30, 2003
Triangle Pharma.
January 30, 2003
Transition Therapeutics.
January 30, 2003
Progenics Pharmaceuticals.
January 30, 2003
ProCyte.
January 30, 2003
Praecis Pharmaceuticals.
January 30, 2003
MacroChem Corp.
January 30, 2003
OXO Chemie.
January 30, 2003
OXIS.
January 30, 2003
Oxigene.
January 30, 2003
Oxford GlycoSciences.
January 30, 2003
Ostex.
January 30, 2003
Oxford BioMedica.
January 30, 2003
Osiris Therapeutics.
January 30, 2003
Osteotech.
January 30, 2003
OSI Pharmaceuticals.
January 30, 2003
Orthovita.
January 30, 2003
Supergen.
January 30, 2003
Synaptic.
January 30, 2003
Stressgen.
January 30, 2003
Stratagene Holding Corp.
January 30, 2003
SpectRx.
January 30, 2003
Pharsight Corp.
January 30, 2003
Pharmos.
January 30, 2003
Pharming.
January 30, 2003
PharmaKinetics Laboratories.
January 30, 2003
Pharmaceutical Product Development.
January 30, 2003
Penwest.
January 30, 2003
Paracelsian.
January 30, 2003
Palatin Technologies.
January 30, 2003
Pain Therapeutics.
January 30, 2003
Paladin Labs.
January 30, 2003
Spectral Diagnostics.
January 30, 2003
Spectrum Pharmaceuticals.
January 30, 2003
Siga Technologies, Inc.
January 30, 2003
Sicor Inc.
January 30, 2003
Shire Pharmaceuticals.
January 30, 2003
|
